Logo image of DUOL

DUOLINGO (DUOL) Stock Fundamental Analysis

NASDAQ:DUOL - Nasdaq - US26603R1068 - Common Stock - Currency: USD

397  -6.06 (-1.5%)

After market: 395.049 -1.95 (-0.49%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DUOL. DUOL was compared to 71 industry peers in the Diversified Consumer Services industry. DUOL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DUOL is valued quite expensive, but it does show an excellent growth. These ratings could make DUOL a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

DUOL had positive earnings in the past year.
In the past year DUOL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: DUOL reported negative net income in multiple years.
DUOL had a positive operating cash flow in each of the past 5 years.
DUOL Yearly Net Income VS EBIT VS OCF VS FCFDUOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

DUOL has a better Return On Assets (6.90%) than 74.65% of its industry peers.
The Return On Equity of DUOL (10.82%) is better than 70.42% of its industry peers.
The Return On Invested Capital of DUOL (6.63%) is better than 77.46% of its industry peers.
Industry RankSector Rank
ROA 6.9%
ROE 10.82%
ROIC 6.63%
ROA(3y)0.17%
ROA(5y)-3.51%
ROE(3y)0.73%
ROE(5y)-5%
ROIC(3y)N/A
ROIC(5y)N/A
DUOL Yearly ROA, ROE, ROICDUOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

DUOL has a better Profit Margin (11.93%) than 74.65% of its industry peers.
With a decent Operating Margin value of 8.76%, DUOL is doing good in the industry, outperforming 66.20% of the companies in the same industry.
DUOL has a better Gross Margin (72.25%) than 88.73% of its industry peers.
In the last couple of years the Gross Margin of DUOL has remained more or less at the same level.
Industry RankSector Rank
OM 8.76%
PM (TTM) 11.93%
GM 72.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.17%
GM growth 5Y0.6%
DUOL Yearly Profit, Operating, Gross MarginsDUOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DUOL is destroying value.
DUOL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DUOL has been increased compared to 5 years ago.
DUOL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DUOL Yearly Shares OutstandingDUOL Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
DUOL Yearly Total Debt VS Total AssetsDUOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 22.89 indicates that DUOL is not in any danger for bankruptcy at the moment.
The Altman-Z score of DUOL (22.89) is better than 95.77% of its industry peers.
There is no outstanding debt for DUOL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 22.89
ROIC/WACC0.74
WACC8.93%
DUOL Yearly LT Debt VS Equity VS FCFDUOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.68 indicates that DUOL has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.68, DUOL is doing good in the industry, outperforming 78.87% of the companies in the same industry.
DUOL has a Quick Ratio of 2.68. This indicates that DUOL is financially healthy and has no problem in meeting its short term obligations.
DUOL's Quick ratio of 2.68 is amongst the best of the industry. DUOL outperforms 80.28% of its industry peers.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 2.68
DUOL Yearly Current Assets VS Current LiabilitesDUOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

DUOL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.25%, which is quite impressive.
DUOL shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.16%.
DUOL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.24% yearly.
EPS 1Y (TTM)108.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)39.16%
Revenue growth 3Y43.94%
Revenue growth 5Y60.24%
Sales Q2Q%37.69%

3.2 Future

The Earnings Per Share is expected to grow by 52.84% on average over the next years. This is a very strong growth
Based on estimates for the next years, DUOL will show a very strong growth in Revenue. The Revenue will grow by 21.76% on average per year.
EPS Next Y63.42%
EPS Next 2Y56.02%
EPS Next 3Y52.84%
EPS Next 5YN/A
Revenue Next Year34.08%
Revenue Next 2Y30.41%
Revenue Next 3Y28.73%
Revenue Next 5Y21.76%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DUOL Yearly Revenue VS EstimatesDUOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B
DUOL Yearly EPS VS EstimatesDUOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 196.53, the valuation of DUOL can be described as expensive.
DUOL's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.28. DUOL is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 87.22, the valuation of DUOL can be described as expensive.
DUOL's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of DUOL to the average of the S&P500 Index (21.76), we can say DUOL is valued expensively.
Industry RankSector Rank
PE 196.53
Fwd PE 87.22
DUOL Price Earnings VS Forward Price EarningsDUOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

DUOL's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DUOL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 62.46
EV/EBITDA 206.21
DUOL Per share dataDUOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DUOL does not grow enough to justify the current Price/Earnings ratio.
DUOL's earnings are expected to grow with 52.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.1
PEG (5Y)N/A
EPS Next 2Y56.02%
EPS Next 3Y52.84%

0

5. Dividend

5.1 Amount

DUOL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DUOLINGO

NASDAQ:DUOL (7/2/2025, 7:06:13 PM)

After market: 395.049 -1.95 (-0.49%)

397

-6.06 (-1.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners93.94%
Inst Owner Change2.39%
Ins Owners0.8%
Ins Owner Change-6.09%
Market Cap18.04B
Analysts75.86
Price Target499.14 (25.73%)
Short Float %4.92%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.92%
Min EPS beat(2)-39%
Max EPS beat(2)37.15%
EPS beat(4)3
Avg EPS beat(4)22.51%
Min EPS beat(4)-39%
Max EPS beat(4)56.25%
EPS beat(8)7
Avg EPS beat(8)67.4%
EPS beat(12)11
Avg EPS beat(12)57.81%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.43%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.27%
Max Revenue beat(4)1.43%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.32%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.56%
PT rev (3m)27.21%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)22.5%
EPS NY rev (1m)1.09%
EPS NY rev (3m)10.67%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)2.59%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)2.45%
Valuation
Industry RankSector Rank
PE 196.53
Fwd PE 87.22
P/S 22.24
P/FCF 62.46
P/OCF 58.65
P/B 20.19
P/tB 20.87
EV/EBITDA 206.21
EPS(TTM)2.02
EY0.51%
EPS(NY)4.55
Fwd EY1.15%
FCF(TTM)6.36
FCFY1.6%
OCF(TTM)6.77
OCFY1.7%
SpS17.85
BVpS19.67
TBVpS19.02
PEG (NY)3.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.9%
ROE 10.82%
ROCE 7.49%
ROIC 6.63%
ROICexc N/A
ROICexgc N/A
OM 8.76%
PM (TTM) 11.93%
GM 72.25%
FCFM 35.61%
ROA(3y)0.17%
ROA(5y)-3.51%
ROE(3y)0.73%
ROE(5y)-5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.17%
GM growth 5Y0.6%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 151.48%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 368.72%
Profit Quality 298.59%
Current Ratio 2.68
Quick Ratio 2.68
Altman-Z 22.89
F-Score6
WACC8.93%
ROIC/WACC0.74
Cap/Depr(3y)198.48%
Cap/Depr(5y)200.07%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y63.42%
EPS Next 2Y56.02%
EPS Next 3Y52.84%
EPS Next 5YN/A
Revenue 1Y (TTM)39.16%
Revenue growth 3Y43.94%
Revenue growth 5Y60.24%
Sales Q2Q%37.69%
Revenue Next Year34.08%
Revenue Next 2Y30.41%
Revenue Next 3Y28.73%
Revenue Next 5Y21.76%
EBIT growth 1Y500.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year329.72%
EBIT Next 3Y102.89%
EBIT Next 5Y61.95%
FCF growth 1Y438.98%
FCF growth 3Y347%
FCF growth 5YN/A
OCF growth 1Y390.64%
OCF growth 3Y214.6%
OCF growth 5Y165.85%